Govt walks a fine line between providing safeguards for health consumers, and maximising the potential for export growth trading off NZ's clean, green brand, writes Jonathan Milne.
UBS AG announced today the per-security amounts payable (collectively, the "Call Settlement Amounts") for the below seven UBS-issued exchange traded notes set forth in the following table ...
The pet supplement market in North America was valued at approximately US$ 1,406.8 million in 2023 and is projected reach valuation of US$ 2,258.3 million by 2032 at a CAGR of 5.4% from 2023 to 2032.
With a growing portfolio in an attractive rare-disease niche—and acceleration of profit growth beginning in 2022—BioMarin could be an acquisition target for pharmaceutical firms with pipelines to fill ...
The company is focused on the development, supply, and manufacturing of amino acids, nutritional supplements, and active pharma ingredients for the pharmaceutical, nutraceutical, and food industries.